SCHEMBL2900685

SCHEMBL2900685

COc1ccc(-c2csc(NCCCOc3cc(C)c(OC(C)(C)C(=O)O)cc3C)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.46
WNT3A P56704 1/20 0.46
PPARD Q03181 1/20 0.45
PPARA Q07869 1/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
LMNA P02545 4/20 0.45
RAB9A P51151 4/20 0.45
MAPT P10636 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 3/20 0.44
TP53 P04637 2/20 0.44
MAPK1 P28482 2/20 0.44
CSNK2A1 P68400 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2901356 0.97 WNT3A (0.47) PTPN1WNT3APPARDPPARASMN1; SMN2
SCHEMBL2901183 0.91 PPARD (0.49) PTPN1PPARDPPARACSNK2A1HDAC3
SCHEMBL2906846 0.91 RAB9A (0.48) PTPN1WNT3APPARDPPARASMN1; SMN2
SCHEMBL2906469 0.89 PPARD (0.49) PPARDPPARACSNK2A1HDAC3HDAC4
SCHEMBL2901181 0.89 PPARD (0.47) PPARDPPARARAB9AMAPTMEN1
SCHEMBL2900976 0.86 PPARD (0.47) PTPN1PPARDPPARARAB9AMAPT
SCHEMBL2906603 0.86 PPARD (0.48) PPARDPPARAMEN1KMT2AALDH1A1
SCHEMBL2904008 0.82 KMT2A (0.50) PPARDPPARALMNARAB9AMAPT
SCHEMBL2901278 0.81 KMT2A (0.47) PPARDPPARALMNARAB9AMAPT
SCHEMBL2904024 0.80 PPARD (0.57) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP claimed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US claimed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP claimed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO claimed
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP disclosed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR PPARD, PPARG, PPARA PTPN1 1084/4885WNT3A 2918/4885PPARD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.